A viral dynamic model for treatment regimens with direct-acting antivirals for chronic hepatitis C infection. - Wikidata - awgldk - TriplyDB

A viral dynamic model for treatment regimens with direct-acting antivirals for chronic hepatitis C infection.

A viral dynamic model for treatment regimens with direct-acting antivirals for chronic hepatitis C infection.

http://www.wikidata.org/entity/Q34126254

about

HCV Kinetic Models and Their Implications in Drug Development Viral kinetic modeling: state of the art Modelling hepatitis C therapy--predicting effects of treatment Modeling viral evolutionary dynamics after telaprevir-based treatment Treatment of hepatitis C with an interferon-based lead-in phase: a perspective from mathematical modelling Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patients Analysis of hepatitis C virus decline during treatment with the protease inhibitor danoprevir using a multiscale model Evolution of virulence in emerging epidemics.Severity of liver disease affects HCV kinetics in patients treated with intravenous silibinin monotherapy Telaprevir-based treatment effects on hepatitis C virus in liver and blood.A pharmacokinetic/viral kinetic model to evaluate the treatment effectiveness of danoprevir against chronic HCV.Mathematical modelling of HCV infection: what can it teach us in the era of direct-acting antiviral agents?Mathematical analysis of multiscale models for hepatitis C virus dynamics under therapy with direct-acting antiviral agents.Telaprevir: clinical pharmacokinetics, pharmacodynamics, and drug-drug interactions.Pharmacokinetic and pharmacodynamic evaluation of telaprevir for the treatment of hepatitis C.Modeling population heterogeneity in viral dynamics for chronic hepatitis C infection: Insights from Phase 3 telaprevir clinical studies.A pharmacokinetic/viral kinetic model to evaluate treatment of chronic HCV infection with a non-nucleoside polymerase inhibitor.New tools in HCV diagnosis, in light of the enhanced awareness and the new drugs for treatment: SMARTube and stimmunology

P2860

Q26801602-894AE2D8-61A3-417B-A3DF-B54529AD9E6F Q26824655-ADD778DA-DF5B-48B0-B5D7-83FF122BF253 Q26864673-86B0FCB6-8A10-498B-B710-07E798C9C636 Q28542375-66A492A4-0FC5-4D43-89D9-3E434F4A3A3B Q30583856-867C4603-BA01-4CE1-BF76-6A7B7B5D4B8B Q34057340-DA275047-66E4-45B4-AFD0-195E333651BF Q34334375-5A1054F8-97D6-47A7-93C3-DE56ECBC130C Q34629148-67BB5F6C-C66A-49E3-9599-2D987922230E Q34675037-80948CA8-F0DE-4A9A-AF88-3C2BD20A3A20 Q35129251-DCB5CDBE-2C53-45CF-9199-B2D84813F104 Q35449696-6237C861-9B27-4C28-BCAA-B7298182F606 Q36810400-0842684B-9EE8-42C8-81DB-EBA8C2CE2C07 Q37138516-C0C3C603-E2E8-443B-9B04-6BBDD03A0570 Q38095820-7742DB27-2F57-442F-A7F8-01C64D401C19 Q38500364-35869A87-B546-49BC-86B6-70DB94BDA4D5 Q40625825-7C709D50-8E74-4C75-A507-ED67B2F13E83 Q47556299-05ACE1F0-C06B-41D0-B2EE-072CAFC04191 Q56916502-A6632F49-10AB-4FE2-9E24-DAC8F4003D5A

P2860

A viral dynamic model for treatment regimens with direct-acting antivirals for chronic hepatitis C infection.

http://www.wikidata.org/entity/Q34126254

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

A viral dynamic model for trea ...... chronic hepatitis C infection.

@ast

A viral dynamic model for trea ...... chronic hepatitis C infection.

@en

A viral dynamic model for trea ...... chronic hepatitis C infection.

@nl

type

label

A viral dynamic model for trea ...... chronic hepatitis C infection.

@ast

A viral dynamic model for trea ...... chronic hepatitis C infection.

@en

A viral dynamic model for trea ...... chronic hepatitis C infection.

@nl

prefLabel

A viral dynamic model for trea ...... chronic hepatitis C infection.

@ast

A viral dynamic model for trea ...... chronic hepatitis C infection.

@en

A viral dynamic model for trea ...... chronic hepatitis C infection.

@nl

P1433

Q34126254-BE840BFC-0B0E-4B49-9AF5-FEEB72EAD2D3

P1476

Q34126254-8CB9A566-ECF6-4EAE-B0ED-062609AEE9A8

P2093

Q34126254-1C8FE64D-E7A6-4C93-A9F3-CFB042C78702

Q34126254-3A787C2C-4779-4C66-A263-4F1D27FC90C4

Q34126254-3B1F920D-574A-4EA1-9DC8-7E8EC79F5187

Q34126254-4B3A3A74-ED4A-4AAC-B743-05C71B39D04B

Q34126254-7005F8D9-AB66-4EEC-8DA6-F0AA04EC0DEF

Q34126254-75CFE0A7-DAAA-48E2-A752-DC6674D21761

Q34126254-A340F4BF-15A5-4FB2-AB73-E9EC943A2EBB

Q34126254-BCC912E7-E384-438A-8105-2CE3EF2DC259

P2860

Q34126254-015BD64F-CA17-46C0-9B8E-E63F76AACF99

Q34126254-0C2EDB7E-4A55-4AD4-85A3-B42D8B5C2C6A

Q34126254-19505908-E405-4FF0-B492-0F3C35320A3B

Q34126254-21B9E150-F98F-40DA-8ADF-1DAF03BB42AC

Q34126254-31AE1D03-2EC2-4FBE-ACB6-6F5686D81777

Q34126254-3633F81B-56D2-4701-8F05-7FB75D4BC1D1

Q34126254-3ACC5ABB-17AB-4541-BFE1-ACB300D2E950

Q34126254-3CDBE193-8655-4A80-8954-643CE15360A1

Q34126254-41E3D37C-06D0-4708-9070-781A8256D460

Q34126254-437E61A1-1B19-4B96-8498-4B544D14A093

P304

Q34126254-C1B3A24F-6BCD-42C7-B770-999202CE49D4

P31

Q34126254-DD8BE79D-7A9A-4102-B194-1CFC8B36A2BD

P356

Q34126254-FF47F093-BCD6-45E2-B72B-D162374902D6

P433

Q34126254-B0173EFA-4B21-41FC-A432-C7EC4BD3B27A

P478

Q34126254-C608FFCD-3FA3-4928-A56C-A04A21CA9B69

P577

Q34126254-DC17FBE7-A1C9-4EAA-8AA3-40D66B80BFAF

P5875

Q34126254-16879185-8B48-449F-89CB-A6F61F2E96E9

P698

Q34126254-BCBE43B6-26CF-49CB-9527-077E02067E92

P932

Q34126254-5BC02614-D4C6-4926-8906-0995FFE03A93

P356

JOURNAL.PCBI.1002339

P1433

PLOS Computational Biology

P1476

A viral dynamic model for trea ...... chronic hepatitis C infection.

@en

P2093

Bambang S Adiwijaya

http://www.w3.org/2001/XMLSchema#string

Holly Kimko

http://www.w3.org/2001/XMLSchema#string

John J Alam

http://www.w3.org/2001/XMLSchema#string

Joshua Henshaw

http://www.w3.org/2001/XMLSchema#string

Karen Eisenhauer

http://www.w3.org/2001/XMLSchema#string

Robert S Kauffman

http://www.w3.org/2001/XMLSchema#string

Tara L Kieffer

http://www.w3.org/2001/XMLSchema#string

Varun Garg

http://www.w3.org/2001/XMLSchema#string

P2860

VX-950, a Novel Hepatitis C Virus (HCV) NS3-4A Protease Inhibitor, Exhibits Potent Antiviral Activities in HCV Replicon Cells

Phenotypic Characterization of Resistant Val36 Variants of Hepatitis C Virus NS3-4A Serine Protease

Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients

Phenotypic and structural analyses of hepatitis C virus NS3 protease Arg155 variants: sensitivity to telaprevir (VX-950) and interferon alpha

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

A multi-variant, viral dynamic model of genotype 1 HCV to assess the in vivo evolution of protease-inhibitor resistant variants

Telaprevir for retreatment of HCV infection

P304

e1002339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PCBI.1002339

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221744657

http://www.w3.org/2001/XMLSchema#string

P698

22241977

http://www.w3.org/2001/XMLSchema#string

P932

3252270

http://www.w3.org/2001/XMLSchema#string